We have studied the binding and interaction of the peptide E1 FP with various model membranes. E1 FP is derived from the amino acid segment 274-291 of the hepatitis C virus envelope glycoprotein E1, which was previously proposed to host the peptide responsible for fusion to target membranes. In the present study we addressed the changes which take place upon E1 FP binding in both the peptide and the phospholipid bilayer, respectively, through a series of complementary experiments. We show that peptide E1 FP binds to and interacts with phospholipid model membranes, modulates the polymorphic phase behavior of membrane phospholipids, is localized in a shallow position in the membrane and interacts preferentially with cholesterol. The capability of modifying the biophysical properties of model membranes supports its role in HCV-mediated membrane fusion and suggests that the mechanism of membrane fusion elicited by class I and II fusion proteins might be similar.
Introduction
Hepatitis C virus (HCV) is a small, enveloped positive singlestranded RNA virus that belongs to the genus Hepacivirus in the family Flaviviridae. HCV is an important public health problem since it is the leading cause of acute and chronic liver disease in humans [1] [2] [3] . The HCV genome shows a remarkable sequence variation since more than 90 genotypes distributed into six main types and subtypes have been identified [2] . There is no vaccine to prevent HCV infection, and current therapeutic agents, apart from being associated to different adverse effects, have limited success against HCV [4] .
The HCV genome consists of one translational open reading frame encoding a polyprotein precursor which is processed to yield different structural and non-structural proteins [5] . HCV entry into the cell is achieved by the fusion of viral and cellular membranes. Morphogenesis and budding has been suggested to take place in the endoplasmic reticulum [6] . The HCV membrane fusion process is pH-dependent, and low endosomal pH promotes the arrangement of the HCV E1/E2 glycoproteins to its active form [7] . The variability of the HCV proteins gives the virus the ability to escape the host's immune surveillance system and the development of a vaccine is a difficult task [8] . Finding protein-membrane and protein-protein interaction inhibitors could be a good strategy against HCV infection since they might prove to be potential therapeutic agents.
The envelope transmembrane glycoproteins E1 and E2 are anchored to the host cell-derived double-layer lipid envelope. They are essential for entry, binding to receptors and induce fusion with the host-cell membrane as well as in viral particle assembly [9] . These proteins interact with each other and assemble as non-covalent heterodimers; their transmembrane domains (TM) play a major role in heterodimer formation, membrane anchoring and endoplasmic reticulum retention [10] . Studies with HCV pp bearing functional E1 and E2 glycoproteins have probed that HCV viral fusion is dependent on the presence of both E1 and E2 glycoproteins [11] . The presence of cholesterol in target membranes facilitates, but is not essential for, HCV pp -mediated fusion [11] . E1 and E2 are class II fusion proteins with the putative fusion peptide/peptides which is/are supposedly localized in an internal sequence linked by antiparallel β-sheets [12, 13] . Many aspects regarding the function and properties of both HCV E1 and E2 glycoproteins still remain unresolved; even so, the location of the fusion peptide is controversial since several data suggest that it could be located in either E1 or E2 or both [7, 11, [14] [15] [16] .
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Abbreviations: 16NS, 16-Doxyl-stearic acid; 5NS, 5-Doxyl-stearic acid; BPS, Bovine brain L-α-phosphatidylserine; CF, 5-Carboxyfluorescein; CHOL, Cholesterol; DEPE, 1,2-Dielaidoyl-sn-glycero-3-phosphatidylethanolamine; DHE, Dehydroergosterol; di-8-ANEPPS, 4-(2-(6-(Dioctylamino)-2-naphthalenyl)-(ethenyl)-1-(3-sulfopropyl)-pyridinium inner salt; EPA, Egg L-α-phosphatidic acid; EPC, Egg L-α-phosphatidylcholine; EPG, Egg L-α-phosphatidylglycerol; ESM, Egg sphingomyelin; FPE, Fluorescein-phosphatidylethanolamine; HCV, Hepatitis C virus; LV, Liver lipid extract; LUV, Large unilamellar vesicles; MLV, Multilamellar vesicles; NBD-PE, N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-phosphoethanolamine; N-RhB-PE, Lissamine™ rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine; POPC, 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; SAXD, Small angle X-ray diffraction; T m , Temperature of the gel-to-liquid crystalline phase transitionRecently, we have identified the membrane-active regions of the HCV E1, E2, core and p7 proteins by studying the effect of proteinderived peptide libraries on model membrane integrity [17] [18] [19] . These results indicate the possible location of different segments in these proteins which might be implicated in protein-lipid and proteinprotein interactions, helping us to understand the mechanisms that underlay the interaction between viral proteins and membranes. Proteomics computational tools located the fusion peptide in the E1 region comprised by amino acids 272 to 281. This region contains cysteine residues and a core of aromatic and hydrophobic residues [12] . Peptides derived from this region have significant experimental membranotropic leakage, hemifusion and fusion effects [19] (see Fig. 1 ). Membrane fusion is a complex process that involves several regions of the fusion proteins. The fusion proteins must bring the viral and cellular membranes together, create membrane defects, induce hemifusion and fusion, and form pores within the membranes [20] [21] [22] . In order to elucidate the nature of the interaction between phospholipids and membrane proteins and in particular to understand the structural function of the fusion peptide in E1 HCV, we have characterized the interaction of E1 FP , a peptide derived from the amino acid sequence 274-291 of the HCV E1 glycoprotein fusion domain, with model membranes using biophysical techniques. We demonstrate that the E1 FP peptide strongly partitions into phospholipid membranes, locates in a shallow position in the membrane, increases the dipole membrane potential, and leads to lipid mixing depending on the cholesterol concentration in the membrane. Furthermore, E1 FP increases membrane disorder and stabilizes the presence of non-lamellar structures, without changing the membrane thickness significantly. Thus, our study provides new evidence for the functional role of this region in the membrane fusion mechanism of HCV.
Materials and methods

Materials and reagents
The peptide E1 FP corresponding to the sequence 274 AMYVGDLCG-SIFLVSQLFT 291 from HCV strain 1B4J (with N-terminal acetylation and Cterminal amidation) was obtained from Genemed Synthesis, San Antonio, Texas. The peptide E1 FP was purified by reverse-phase HPLC (Vydac C-8 column, 250 × 4.6 mm, flow rate 1 ml/min, solvent A, 0.1% trifluoroacetic acid, solvent B, 99.9 acetonitrile and 0.1% trifluoroacetic acid) to better than 95% purity, and its composition and molecular mass were confirmed by amino acid analysis and mass spectroscopy. Residual trifluoroacetic acid, used both in peptide synthesis and in the highperformance liquid chromatography mobile phase, was removed by several lyophilisation/solubilisation cycles in 10 mM HCl [23] . Egg L-α-phosphatidylcholine (EPC), egg L-α-phosphatidic acid (EPA), egg sphingomyelin (ESM), bovine brain phosphatidylserine (BPS), egg L-α-phosphatidylglycerol (EPG), cholesterol (CHOL), liver lipid extract (LV), 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine (DEPE), and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) were obtained from Avanti Polar Lipids (Alabaster, AL, USA).
were obtained from Molecular Probes (Eugene, OR). 5-Carboxyfluorescein (CF), (>95% by HPLC), 5-doxyl-stearic acid (5NS), 16-doxyl-stearic acid (16NS), dehydroergosterol (ergosta-5,7,9(11),22-tetraen-3ß-ol, DHE), sodium dithionite, deuterium oxide (99.9% by atom), Triton X-100, EDTA, and HEPES were purchased from Sigma-Aldrich (Madrid, ES). All other Fig. 1 . Hydrophobic moment (HM), hydrophobicity (H), and interfacial hydrophobicity (I) distribution, for HCV E1 envelope glycoprotein [19] assuming that it forms an α-helical wheel [71] . Only positive bilayer-to-water transfer free-energy values are shown (the darker, the greater). A summary of the normalized experimental membrane rupture data (LK) corresponding to 18-mer peptide libraries derived from the whole HCV E1 [19] protein is also shown, as well as the sequence and the location of the E1 FP peptide.
reagents used were of analytical grade from Sigma-Aldrich (Madrid, EU). Water was deionized, twice-distilled and passed through a Milli-Q equipment (Millipore Ibérica, Madrid, ES, EU) to a resistivity better than 18 MΩ cm.
Vesicle preparation
Aliquots containing the appropriate amount of lipid in chloroform/ methanol (2:1, v/v) were placed in a test tube, the solvents removed by evaporation under a stream of O 2 -free nitrogen, and finally, traces of solvents were eliminated under vacuum in the dark for more than 3 h. The lipid films were resuspended in an appropriate buffer and incubated either at 25°C or 10°C above the phase transition temperature (T m ) with intermittent vortexing for 30 min to hydrate the samples and obtain multilamellar vesicles (MLV). The samples were frozen and thawed five times to ensure complete homogenization and maximization of peptide/lipid contacts with occasional vortexing. Large unilamellar vesicles (LUV) with a mean diameter of 0.1 and 0.2 μm for either leakage or lipid mixing and fusion experiments were prepared from multilamellar vesicles by the extrusion method [24] using polycarbonate filters with a pore size of 0.1 and 0.2 μm (Nuclepore Corp., Cambridge, CA, USA). The phospholipid and peptide concentration were measured by methods described previously [25, 26] .
Membrane leakage measurement
LUVs with a mean diameter of 0.1 μm were prepared as indicated above in buffer containing 10 mM Tris, 20 mM NaCl, pH 7.4, and CF at a concentration of 40 mM. Non-encapsulated CF was separated from the vesicle suspension through a Sephadex G-75 filtration column (Pharmacia, Uppsala, SW, EU) eluted with buffer containing 10 mM TRIS, 100 mM NaCl, 1 mM EDTA, pH 7.4. Membrane rupture (leakage) of intraliposomal CF was assayed by treating the probe-loaded liposomes (final lipid concentration, 0.125 mM) with the appropriate amounts of peptide using a 5 × 5 mm fluorescence cuvette on a Varian Cary Eclipse spectrofluorometer , stabilized at 25°C with the appropriate amounts of peptide, each cuvette containing a final volume of 400 µl. The medium in the cuvettes was continuously stirred to allow the rapid mixing of peptide and vesicles. Leakage was assayed until no more change in fluorescence was obtained. The fluorescence was measured using a Varian Cary Eclipse spectrofluorometer. Changes in fluorescence intensity were recorded with excitation and emission wavelengths set at 492 and 517 nm, respectively. Excitation and emission slits were set at 5 nm. One hundred percent release was achieved by adding Triton X-100 to the cuvette to a final concentration of 0.5% (w/w). Fluorescence measurements were made initially with probe-loaded liposomes, afterwards by adding peptide solution and finally by adding Triton X-100 to obtain 100% leakage. Leakage was quantified on a percentage basis according to the equation %L =[(F f −F 0 )*100]/(F 100 −F 0 ), where F f is the equilibrium value of fluorescence after peptide addition, F 0 is the initial fluorescence of the vesicle suspension, and F 100 is the fluorescence value after the addition of Triton X-100.
Phospholipid-mixing measurement
Peptide-induced vesicle lipid mixing was measured by resonance energy transfer [27] . This assay is based on the decrease in resonance energy transfer between two probes (NBD-PE and RhB-PE) when the lipids of the probe-containing vesicles are allowed to mix with lipids from vesicles lacking the probes. If both types of vesicles fuse in the presence of the peptide, the surface density of the acceptor is reduced, resulting in a decreased efficiency of resonance energy transfer which is measured experimentally. These changes in transfer efficiency allow quantitative measurements of the lipid-mixing process [31] . The concentration of each of the fluorescent probes within the liposome membrane was 0.6 mol%. LUVs with a mean diameter of 0.2 μm were prepared as described above. Labeled and unlabeled vesicles in a proportion 1:4 were placed in a 5 mm× 5 mm fluorescence cuvette at a final lipid concentration of 100 μM in a final volume of 400 μl, stabilized at 25°C under constant stirring. The fluorescence was measured using a Varian Cary Eclipse fluorescence spectrometer using 467 nm and 530 nm for excitation and emission, respectively. Excitation and emission slits were set at 10 nm. Since labeled and unlabeled vesicles were mixed in a proportion of 1 to 4 respectively, 100% phospholipid mixing was estimated with a liposome preparation in which the membrane concentration of each probe was 0.12% [28] . Phospholipid mixing was quantified on a percentage basis according to the equation % PM = (F f −F 0 )/(F 100 −F 0 )]⋅ 100, F f being the value of fluorescence obtained 15 min after peptide addition to a liposome mixture containing liposomes having 0.6% of each probe plus liposomes without any fluorescent probe, F 0 the initial fluorescence of the vesicles and F 100 as the fluorescence value of the liposomes containing 0.12% of each probe. It should be taken into account that the characteristic lipid flip-flop time is much longer than the lipid-mixing measurement time.
Inner-monolayer phospholipid-mixing (fusion) measurement
Peptide-induced phospholipid mixing of the inner monolayer was measured by a modification of the resonance energy transfer method described above [31] . LUVs prepared as above were treated with sodium dithionite to completely reduce the NBD-labeled phospholipid located at the outer monolayer of the membrane. Final concentration of sodium dithionite was 100 mM (from a stock solution of 1 M dithionite in 1 M TRIS, pH 10.0) and incubated for approximately 1 h on ice in the dark. Sodium dithionite was then removed by size exclusion chromatography through a Sephadex G-75 filtration column (Pharmacia, Uppsala, Sweden) eluted with buffer containing 10 mM TRIS, 100 mM NaCl, and 1 mM EDTA, pH 7.4. The proportion of labeled and unlabeled vesicles, lipid concentration and other experimental conditions were the same as indicated above for the phospholipid-mixing assay. In order to eliminate any artifact in the measurements, for each membrane composition zero values were obtained using the fluorescent values of inner monolayer-labeled vesicles without peptide whereas 100% fusion was estimated with vesicles containing 0.12% of each probe measured at the same time the samples were incubated with the peptide.
Peptide binding to vesicles
The partitioning of the peptide into the phospholipid bilayer was monitored by the fluorescence enhancement of tyrosin. Fluorescence spectra were recorded in a SLM Aminco 8000C spectrofluorometer with excitation and emission wavelengths of 274 and 305 nm, respectively, and 4 nm spectral bandwidths. Measurements were carried out in 20 mM HEPES, 50 mM NaCl, and EDTA 0.1 mM, pH 7.4. Intensity values were corrected for dilution, and the scatter contribution was derived from lipid titration of a vesicle blank. Partitioning coefficients were obtained using
, where I and I 0 are the final and the initial intensities respectively, K P is a mole fraction partition coefficient that represents the amount of peptide in the bilayers as a fraction of the total peptide present in the system, I max is a variable value for the fluorescence enhancement at complete partitioning determined by fitting the equation to the experimental data, [L] is the lipid concentration, and [W] is the concentration of water (55.3 M) [29] . The peptide concentration in the assays was 30 μM.
Fluorescence quenching of Tyr emission by water-soluble and lipophylic probes
For acrylamide quenching assays, aliquots from a 4 M solution of the water-soluble quencher were added to the solution-containing peptide in the presence and absence of liposomes at a peptide/lipid molar ratio of 1:50. The results obtained were corrected for dilution and the scatter contribution was derived from acrylamide titration of a vesicle blank. The data were analyzed according to the Stern-Volmer equation [30] ,
, where F 0 and F represent the fluorescence intensities in the absence and the presence of the quencher [Q], respectively, and K SV is the Stern-Volmer quenching constant, which is a measure of the accessibility of Tyr to acrylamide. Quenching studies with lipophylic probes were performed by successive addition of small amounts of 5NS or 16NS in ethanol to the samples of the peptide incubated with LUV. The final concentration of ethanol was kept below 2.5% (v/v) to avoid any significant bilayer alterations. After each addition an incubation period of 15 min was kept before the measurement. The excitation and emission wavelengths were 274 and 305 nm, respectively. The data were analyzed as previously described [31] .
Fluorescence measurements using FPE-labeled membranes
LUVs with a mean diameter of 0.1 μm were prepared in buffer containing 10 mM TRIS-HCl, pH 7.4. The vesicles were labeled exclusively in the outer bilayer leaflet with FPE as described previously [32] . Briefly, LUVs were incubated with 0.1 mol% FPE dissolved in ethanol (never more than 0.1% of the total aqueous volume) at 37°C for 1 h in the dark. Any remaining unincorporated FPE was removed by gel filtration on a Sephadex G-25 column equilibrated with the appropriate buffer. FPE-vesicles were stored at 4°C until use in an oxygen-free atmosphere. Fluorescence time courses of FPE-labeled vesicles were measured after the desired amount of peptide was added into 400 µl of lipid suspensions (200 μM lipid) using a Varian Cary Eclipse fluorescence spectrometer. Excitation and emission wavelengths were set at 490 and 520 nm, respectively, using excitation and emission slits set at 5 nm. Temperature was controlled with a thermostatic bath at 25°C. The contribution of light scattering to the fluorescence signals was measured in experiments without the dye and was subtracted from the fluorescence traces. The data were analyzed as previously described [28] .
Measurement of the membrane dipole potential using di-8-ANEPPS-labeled membranes
Aliquots containing the appropriate amount of lipid in chloroformmethanol (2:1 v/v) and di-8-ANEPPS were placed in a test tube to obtain a probe/lipid molar ratio of 1:100 and LUVs, with a mean diameter of 90 nm, were prepared as described previously. Steadystate fluorescence measurements were recorded with a Varian Cary Eclipse spectrofluorometer. The excitation ratio, R ex , is defined as the ratio of emission intensity at 620 nm caused by excitation with 450 and 520 nm light [33] . The mechanism by which di-8-ANEPPS operate in order to sense dipole potential is believed to be electrochromic; absorption and emission peaks shift in response to a nearby electrical field that differentially interacts with the ground state and excited state dipole moments of the chromophore [33] . Therefore di-8-ANEPPS can be used as a ratiometric probe of dipole potential but using an excitation ratio [34] . The lipid concentration was 200 µM, and all experiments were performed at 25°C.
FRET with DHE
Vesicles contained POPC/ESM/CHOL at a molar ratio of 50:25:25 plus variable proportions of DHE. The ratio of DHE/CHOL was 0, 0.05, 0.1, 0.17, 0.25, 0.42 and 1. The total lipid concentration was 2 mM and the lipid-to-peptide ratio was 50:1. The suspensions containing both peptide and lipid were incubated overnight. Fluorescence spectra were recorded in a SLM Aminco 8000 spectrofluorometer with excitation at 274 for tyrosine and emission of both tyrosine (donor) and DHE (acceptor) were recorded between 290-500 nm. The experimentally determined values of FRET efficiency, E, were calculated according to [35] .
Small-angle X-ray scattering experiments
MLVs at a concentration of 5% (w/w) prepared without or with the peptide at a lipid/peptide molar ratio of 50:1 were prepared as stated above and submitted to 15 temperature cycles (heating at 45°C and cooling at −20°C). Lipid, at a concentration of 67 mM, was resuspended in buffer containing 20 mM HEPES, and 50 mM NaCl, pH 7.4. Smallangle X-ray diffraction (SAXD) measurements were carried out using a Hecus SWAX-camera (Hecus X-ray Systems, Graz, Austria) as described previously [36] using Ni-filtered Cu-Kα radiation (λ = 1542 Å) originating from a sealed tube X-ray generator (Seifert, Alvenburg, Germany) operating at a power of 2 kW (50 kV, 4 mA). Sample-to-detector distance was 27.8 cm. A linear-position-sensitive detector was used with 1024-channel resolution. SAXD angle calibration was done with silver stearate. The measurements were performed with the sample placed in a thin-walled 1-mm diameter quartz capillary held in a steel cuvette holder at different temperatures with an exposure time of 1 h. The SAXD curves were analyzed after background subtraction and normalization in terms of a full q-range model using the program GAP [37] .
2.12.
P NMR
Samples were prepared as described above at a lipid/peptide molar ratio of 50:1 and concentrated by centrifugation (14,000 rpm for 15 min). 31 P NMR spectra were recorded at different temperatures in the Fourier transform mode in a Bruker Avance 500 MHz NMR (Bruker BioSpin) spectrometer operating at a resonance frequency of 202.38 MHz for 31 P-nuclei using a 4-mm CP-MAS probe. The samples were packed into 4-mm zirconia rotors and placed in the spinning module of the CP-MAS probe; no spinning and no cross-polarization were used. Probe temperature was maintained by a Bruker BVT 3000 variable digital temperature unit. Measurements, spectra acquisition, and calibration were essentially performed as previously described [38] . MAS 31 P NMR spectra were obtained using a Bruker 4-mm CP-MAS probe without cross-polarization. The spinning speed was 9 kHz, regulated to 3 Hz by a Bruker pneumatic unit and the temperature was 25°C. Measurements, spectra acquisition and calibration were essentially performed as previously described [17] . A single 31 P 90°p
ulse, typically of 4 μs, was used for excitation, a gated broadband decoupling of 10 W, 32 k data points, 1600 transients and 5 s delay time between acquisitions.
Hydrophobic moment, hydrophobicity and interfacial hydrophobicity
Hydrophobic moment, hydrophobicity and interfacial hydrophobicity values were obtained from [39] [40] [41] . Two-dimensional plots of the hydrophobic moments, hydrophobicity and interfacial hydrophobicity have been obtained using a window of seven amino acids, taking into consideration the arrangement of the amino acids in the space assuming an α-helical structure [42] . Positive values represent positive bilayer-to-water transfer free-energy values and therefore, i.e., the higher the value, the greater the probability to interact with the membrane surface and/or the hydrophobic core.
Results
The HCV E1 envelope glycoprotein is thought to be responsible for the membrane fusion process whereas the HCV E2 envelope glycoprotein is thought to mediate the binding to the host cell, although other roles could not be ruled out [7, 11, 43] . Several hydrophobic patches have been identified in both the E1 and E2 proteins which might be important for modulating membrane binding and interaction [15, 19] . In Fig. 1 we present the analysis of the hydrophobic moment, hydrophobicity and interfacial hydrophobicity distribution along the E1 envelope glycoprotein sequence of HCV (strain 1B4J) assuming it forms an α-helical wheel along the whole sequence [19] . This analysis renders the potential surface zones that could be implicated in the modulation of membrane binding and/or protein interaction. As depicted in Fig. 1 , the sequence comprising residues 274-291 is one of the most membranotropic regions of HCV E1 [19] and probably this segment participates in the viral fusion process [11] . For this reason we studied the interaction of E1 FP , a peptide which comprises the residues 274-291 of this region, with model membranes. In particular, we have focused on the binding and interaction of E1 FP with lipid bilayers, the changes induced in both the peptide and phospholipid molecules upon membrane binding, as well as the ability to modulate membrane polymorphism. Since we have previously shown that peptide 274-291 did not show any significant difference on membrane rupture at either neutral or acidic pH [19] , we have performed all the assays at neutral pH.
The interaction of the E1 FP peptide with membrane vesicles was followed by the change of the fluorescence emission of the Tyr residue in the presence of model membranes [44] . It is important to note that membrane fusion in HCV pseudo-particles does not require any protein or receptor at the membrane surface. Fusion is additionally enhanced by the presence of CHOL [7, 45] . The quantum yield of a Tyr residue of a peptide or protein normally changes when this amino acid is located in a hydrophobic environment such as a phospholipid membrane, typically leading to an increase of the fluorescence emission intensity. In solution, the E1 FP peptide exhibited absorption and emission maxima at 274 and 304 nm, respectively. The shape and wavelength maximum of the spectra in solution and in the presence of membranes were similar. However, the intensity increased significantly in the presence of membrane vesicles, indicating that the Tyr residue of the peptide was in a hydrophobic environment (Fig. 2A) . In the presence of EPC/CHOL the increase in the intensity was significantly higher than in the presence of vesicles containing either complex lipids such as LV or negatively-charged phospholipid mixtures like BPS/CHOL, EPA/CHOL and EPG/CHOL (all binary lipid compositions had a molar ratio of 5:1) ( Fig. 2A) . This approach allowed us to obtain the peptide partition coefficient, K P , which gave values in the range 10 7 for EPC/CHOL containing liposomes and in the range 10 5 for the other ones. These K P values are consistent with the tenet that the peptide binds with high affinity to the membrane surface [38, 44, 46, 47] . We have also used the electrostatic surface potential probe FPE [48] to analyze the binding of the E1 FP peptide to model membranes (Fig. 2B) . As observed in the figure, E1 FP had a higher affinity for model membranes containing LV and the system BPS/CHOL, i.e., the smallest dissociation constant was found in the presence of these vesicles. In contrast, the lower affinity was found for the system EPG/CHOL. Being both BPS and EPG negatively-charged phospholipids, it is interesting to note that phosphatidylserine is the most abundant negatively-charged phospholipid in the viral and host-cell membranes and is further involved in lamellar to non-lamellar transitions [49] . In all cases the data could be adjusted to a binding profile having either a sigmoidal (Hill coefficient of approximately 1) or a hyperbolic dependence (data not shown) which might suggest that the interaction of the peptide with the membrane was monomeric. Changes in the magnitude of the membrane dipole potential elicited by E1 FP were monitored by the spectral shift of the fluorescence probe di-8-ANEPPS [28] . The variation of the normalized fluorescence intensity ratio R 450/520 as a function of the peptide concentration for different membrane compositions is shown in Fig. 2C . The data demonstrate that the peptide was capable of inserting into the lipid bilayer, leading to a modification of its dipole potential. The binding of the peptide to the membrane could be described by a saturable binding model where the peptide increased the magnitude of the dipole potential of all the phospholipid bilayers. In the presence of the peptide, the strongest decrease in the R 450/520 value was obtained in bilayers containing EPC/CHOL and BPS/CHOL.
We also studied the accessibility of the Tyr residue of E1 FP towards acrylamide, a neutral, water-soluble, highly efficient quenching molecule, which is unable to penetrate into the hydrophobic core of the lipid bilayer. Stern-Volmer plots for the quenching of Tyr by acrylamide are shown in Fig. 3A . The plots are linear with a unitary intercept showing that the Stern-Volmer dynamic quenching formalism accurately describes the data. In aqueous solution the Tyr residue was highly exposed to the solvent that led to a more efficient quenching. The lower K SV values obtained in the presence of lipids compared with the higher ones in their absence, suggest that the peptide is buried in the membrane, becoming less accessible for quenching by acrylamide. Interestingly, the K SV values in the presence of EPC/CHOL and LV containing vesicles were greater than in the presence of negativelycharged phospholipids, indicating that the peptide would be located less deeply inside the membrane in the presence of the later phospholipids.
The transverse location of E1 FP into the lipid bilayer was evaluated by monitoring the relative quenching of the fluorescence of the Tyr residue by the lipophylic spin probes 5NS and 16NS (Fig. 3B) . For 5NS and 16NS, the nitroxide groups are located at about 12 Å and at 3 Å from the bilayer centre [50] , so that the direct comparison of the Stern-Volmer plots provides a qualitative method to determine the penetration of the peptide within the bilayer. In general, the peptide was quenched more efficiently by 5NS than by 16NS, suggesting that the peptide remained close to the lipid/water interface. However, the most efficient quenching takes place in membranes composed of EPC/ CHOL and LV, indicating that the location of the peptide in the presence of the zwitterionic lipids is deeper than in the presence of negatively-charged phospholipids.
To examine the effect of E1 FP in the destabilization of membrane vesicles, we have studied its effect on membrane rupture, i.e., leakage (Fig. 4A) . The peptide induced a significant, dose-dependent, leakage effect in all membrane systems studied (at the highest peptide to lipid ratio studied, i.e., 1:5, leakage values were about 95-100%). However, the highest leakage effect was observed for liposomes composed of a LV (Fig. 4A ). This data shows that all these membranes are perturbed by the E1 FP peptide at all lipid/peptide ratios tested. Membrane perturbation is not sufficient to complete the process of membrane fusion, but also the merging of the monolayers and the stalk formation [22] . Therefore, we have also studied the effect of the peptide on both phospholipid mixing and fusion using a probe dilution assay [27, 51] . As shown in Fig. 4B and C, the higher phospholipid mixing and fusion values were found for liposomes containing either EPC/CHOL or LV (about 95-100% phospholipid mixing and 80-100% fusion at a peptide to lipid ratio of 1:5), whereas BPS/CHOL, EPG/CHOL and EPA/CHOL displayed lower but also significant values (about 40% phospholipid mixing and 35% fusion at a peptide to lipid ratio of 1:5). Therefore, the lower phospholipid mixing and fusion values were found for liposomes containing negativelycharged phospholipids.
The presence of both sphingomyelin and CHOL has been related to the occurrence of laterally segregated membrane microdomains or "lipid rafts". Interestingly, it has been found for several viruses that there is an important relationship between membrane fusion and the presence of CHOL and sphingomyelin in membranes [52] . In this context, it is further interesting to note that the presence of CHOL has been recently reported to facilitate the fusion of HCV pp with the target membrane [53] . Therefore, we have tested the possibility that CHOL could mediate the interaction of the E1 FP peptide with the membrane. Since the energetic barrier for hemifusion is larger than leakage [45] , we have chosen lipid mixing to study the possible dependence of E1 FP with CHOL. The extent of phospholipid mixing for a number of different POPC/ESM/CHOL compositions at different lipid-to-peptide ratios is shown in Fig. 5A . Significantly, at relatively low lipid/peptide ratios, the higher the CHOL content, the higher the mixing. The dependence of leakage on the molar ratio of each component in the mixture is shown in Fig. 5B . It is readily observed that an increase of the EPC molar ratio leads to a decrease of lipid mixing. In contrast, the content of CHOL correlates directly with an increase of lipid mixing. No pattern can be discerned by changing the molar ratio of ESM (Fig. 5B) . These results show that the content of CHOL in the sample is critical for lipid mixing. Probably E1 FP interacts specifically with CHOL and/or its effects exerted on membranes depend on its presence. A representation of all studied POPC/ESM/CHOL compositions is shown as a ternary phase diagram in the insert of Fig. 5A . Since this ternary diagram is comparable with that of POPC/PSM/CHOL [54] , all samples studied here would have a coexistence of liquid-ordered and liquiddisordered phases, i.e., a high probability of lipid raft domains. It can be also observed that the maximum phospholipid mixing should be obtained at a theoretical lipid composition consisting of about 80% CHOL and about 20% ESM (dotted lines, insert of Fig. 5A ). To further confirm the adsorption of E1 FP to CHOL in membranes, we have used a fluorescence resonance energy transfer between the fluorescent cholesterol analogue, dehydroergosterol (acceptor) and Tyr (donor) [59] using LUVs of POPC/ESM/(CHOL/DHE) at a molar ratio of 2:1:1 containing different DHE concentrations. As shown in Fig. 5C , an increase in energy transfer efficiency with increasing DHE concentration, higher than the expected on the basis random distribution, was observed. Therefore, the Tyr residue of the E1 FP peptide was in the vicinity of DHE, i.e., adsorption occurred.
Information on the structural organization of a mixture containing POPC/ESM/CHOL at a molar ratio of 5:1:1 in the absence and in the presence of the E1 FP peptide was studied by small-angle X-ray diffraction, SAXD (Fig. 6A) . This technique defines the macroscopic structure and provides the interlamellar repeat distance in the lamellar phase which comprises both the bilayer and the water layer thickness. The structural results from the global data analysis are shown in the insert of Fig. 6A . Both in the absence and in the presence of the peptide, the diffraction pattern corresponded to the liquidcrystalline L α phase, showing an interlamellar repeat distance of 67.9 Å for the pure lipid mixture and 70.5 Å in the presence of peptide. The membrane thickness decreased from 43.3 Å in the absence of the peptide to 39.5 Å in its presence. However the thickness of the water layer increased from 24.6 Å to 31.0 Å under the same conditions. Visually, the most significant effect was the increase of the diffuse scattering in the presence of the peptide indicating that several bilayers have become positional uncorrelated due to its influence.
Since the P line widths at half height were 42.5 Hz and 51 Hz for POPC and ESM respectively, whereas they shifted to 70.4 Hz and 109.9 Hz for POPC and ESM respectively when the peptide was present. These results show that both phospholipids, POPC and ESM, exhibit a lower degree of mobility and/ or an increased heterogeneity of headgroup environments in the presence of the peptide. However, ESM showed a higher increase in width at half height than POPC.
Phosphatidylethanolamines in general and DEPE in particular display a gel-to-liquid crystalline phase transition, L β -L α , and a lamellar-to-inverted hexagonal phase transition, L α -H II . Information on the structural organization of DEPE and DEPE in the presence of peptide was obtained also by SAXD. The diffraction patterns of pure DEPE and DEPE in the presence of the peptide from 25°to 80°are shown in Fig. 7A and B, respectively. Between 25°C and 60°C the diffraction patterns of pure DEPE were characteristic of the lamellar phase, whereas at higher temperatures the hexagonal phase was detected. In the presence of the peptide, a coexistence of gel and liquid-crystalline phases was apparent at 35°C (Fig. 7B) . At 60°C reflections characteristic of the hexagonal phase appeared with a residual refraction of the lamellar phase at higher temperatures (Fig. 7B) . Thus, E1 FP leads to an increase of both transition widths.
DEPE when organized in bilayer structures gives rise to an asymmetrical 31 P NMR line-shape with a high-field peak and a low-field shoulder, presenting a residual chemical shift anisotropy, Δσ, of 36-40 ppm in the gel state and 27-30 ppm in the liquid-crystalline state [55] . In the H II phase the chemical shift anisotropy is further averaged due to rapid lateral diffusion of the phospholipid around the tubes of which this phase is composed, resulting in a line-shape with reverse symmetry, i.e., a high-field shoulder and a low-field peak, accompanied by a twofold reduction in the absolute value of Δσ. This was the behavior we found for pure DEPE as expected (Fig. 7C) . However, when E1 FP was added to attain a lipid/peptide molar ratio of 50:1, the NMR profile of DEPE was different, since, beginning at approximately 55°C, an isotropic peak at 0 ppm was apparent, and significantly, a mixture of both lamellar and hexagonal phases was observed at 60°C, in concordance with the SAXD data shown above (Fig. 7D) . 
Discussion
Envelope fusion class I and class II glycoproteins, located on the outer surface of the viral membranes, mediate the fusion of the viral and cellular membranes [56, 57] . Significantly, class I and class II membrane fusion proteins share structural and functional characteristics in specific domains which interact with and disrupt biological membranes [12, [56] [57] [58] . It is known that both HCV E1 and E2 envelope glycoproteins are essential for receptor binding, host-cell entry and membrane fusion; however, their specific roles in the different processes of the viral life cycle are not known [9, 11, 43, 59, 60] . Moreover, membrane fusion does not necessarily occur at the plasma membrane level; viral entry can also involve endocytosis and vesicular trafficking, as it happens in the case of HCV. The E1/E2 heterodimer is thought to be the functional fusion unit, capable of juxtaposing, destabilizing and merging the viral and cellular membranes so that a fusion-pore is formed. Low-pH would induce its dissociation leading to homo-oligomerization of the active form of the fusion protein [11, [60] [61] [62] . Several hydrophobic segments have been identified in both E1 and E2 envelope glycoproteins which might be important in the mechanism of membrane fusion, not only for modulating membrane binding and interaction, but also for proteinprotein interaction [15, 16, 19, 43, 63] . These segments bind and destabilize the biological membrane, and these interactions should be decisive for membrane fusion. In this work we have characterized the interaction of E1 FP , a peptide derived from one of the most membranotropic regions the HCV E1 glycoprotein (amino acids 274-291), with model membranes. This study provides new evidence for the functional role of this region in the membrane fusion mechanism of HCV.
E1 FP binds with high affinity to different types of phospholipid model membranes. The main binding force is apparently of hydrophobic origin, most likely due to the high hydrophobicity and interfacial hydrophobicity values shown in the peptide sequence (Fig. 1) . After binding, the peptide decreased the dipole potential of the membrane. Even though the Tyr residue is located in the N-terminal part of E1 FP , we have been able to study the binding of the peptide to membrane vesicles by hydrophilic and lipophilic quenching probes. E1 FP was less accessible for quenching by acrylamide in the presence of zwitterionic and complex phospholipids than in the presence of negatively-containing membranes, implying a buried location in the former compositions. Similar results were obtained in the presence of NS probes, since a higher quenching efficiency was observed for model membranes containing zwitterionic and complex phospholipids (i.e., liver lipid extract). Nevertheless, the peptide was capable of binding with high affinity to model membranes containing both negatively-charged and zwitterionic phospholipids and it was located near the membrane lipid/water interface.
E1 FP disrupted the membrane causing the release of fluorescent probes. This effect was found to depend on lipid composition and on the lipid/peptide molar ratio. The highest effect was observed for liposomes containing a complex mixture of phospholipids, but lower although significant leakage values were also observed for liposomes composed of zwitterionic and negatively-charged phospholipids. The induction of lipid mixing and fusion by E1 FP were also studied and similar results were obtained, since specific and large membrane lipid mixing and fusion values were found in the presence of liposomes composed of complex, negatively-charged and zwitterionic phospholipids. Membrane rupture by E1 FP is therefore mainly due to hydrophobic interactions within the bilayer; however, the charge of the phospholipid headgroups also affects to some extent membrane leakage. Interestingly, the presence of CHOL has recently been described to facilitate the fusion with the target membrane of HCV pp [53] . We demonstrate here that CHOL indeed is one of the major determinants of the effects produced by E1 FP on membranes since it specifically interacts with CHOL and its effect depends on the molar ratio of this molecule. Even so, the presence of raft domains could be also decisive for the biological function of the protein region where the E1 FP peptide resides.
Moreover, the presence of E1 FP decreased membrane thickness and increased its hydration layer and at the same time induced the presence of positionally uncorrelated bilayers. Membrane thinning is a frequently found response of lipid bilayers to binding of peptides [64] , but not necessarily a universal behavior [65] . It can be understood as the formation by the surface adsorbed peptide of a local dimple [66] that leads to a global decrease of the bilayer thickness. This effect will lead to an overall decrease of the bending rigidity, which facilitates fusion by reducing the free-energy barriers for passing through highly curved intermediate states [67] . Indeed, the increase of the water layer, as well as the partial loss of positional correlations between adjacent bilayers indicate membrane softening, driving some of the stacked bilayers into an unbound state [68, 69] . Additionally, the phosphate groups of the phospholipid molecules displayed a lower degree of mobility and/or an increased heterogeneity of headgroup environments in the presence of E1 FP . This result strengthens that the location of the peptide is at or near the membrane interface. Interestingly, E1 FP changed the polymorphic phase behavior of the membranes, since it induced the presence of an H II phase at slightly lower temperatures than in pure DEPE bilayers.
In conclusion, E1 FP was able to affect the elastic and structural properties of lipid bilayers, leading to a significant effect on both membrane fusion and leakage, which also depended upon the concentration of CHOL [53] . These effects are possibly related to the conformational changes which might occur on E1 glycoprotein during the fusion process. As it has been suggested previously, the E1 region where E1 FP resides might have an essential role in the membrane fusion process, as it has been observed for other analogous proteins (i.e., HIV gp41). In principle only peptides affecting the lipid polymorphic phase behavior could be located in regions implicated in a stabilization/ destabilization role of lamellar/non-lamellar structures, the role needed for membrane fusion. Furthermore, E1 FP would interact with the membrane through both electrostatic and hydrophobic effects, leading to an adsorption to the membrane interface. It is known that several fusion peptide fragments are prone to promote the formation of local nipples in the cell membrane leading to the formation of local bends and therefore non-lamellar phases needed for the fusion process [70] . Therefore, this implies that both HCV E1 and E2 glycoproteins are directly involved in the mechanism that facilitates the entry of the HCV virus into its cellular host. Whereas other membranotropic segments would be implicated in membrane destabilization, pore formation and enlargement, fusion peptides from both E1 and E2 would be of importance in the very first steps of membrane fusion. 
